Denali Therapeutics Inc (NAS:DNLI)
$ 20.61 -0.71 (-3.33%) Market Cap: 2.97 Bil Enterprise Value: 2.28 Bil PE Ratio: 0 PB Ratio: 2.25 GF Score: 57/100

Denali Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 03, 2020 / 05:00PM GMT
Release Date Price: $28.82 (+1.44%)
Ryan J. Watts
Denali Therapeutics Inc. - Co-Founder, President, CEO & Director

The Annual Meeting of Stockholders of Denali Therapeutics Inc. is called to order. My name is Ryan Watts, and as provided in the company's bylaws, I will act as Chairman of the meeting. Dr. Alex Schuth, Chief Operating Officer and Secretary of Denali, will act as Secretary of the meeting.

This year, we are holding a virtual Annual Meeting of Stockholders. We are sensitive to the health, safety and travel concerns of our stockholders and the regulations, protocols and other requirements that federal, state and local governments have imposed in response to the COVID-19 pandemic. The virtual meeting enables our stockholders no matter where they are located in the world today to participate in the annual meeting virtually.

If you have an 11-digit voting control number issued by American Stock Transfer & Trust Company, LLC, our company's transfer agent, and wish to vote during this meeting, you may do so by clicking the proxy vote link on the left-hand panel of your screen. You may also ask questions

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot